Biotech | December 13, 2021
Zydus to begin Phase II (a) clinical trial of ZYIL1 in Australia
It is a novel oral NLRP3 inflammasome inhibitor
It is a novel oral NLRP3 inflammasome inhibitor
The company will provide recyclability services to brands with a final goal to help them move to fully recyclable packaging
It is an extension of GE Healthcare’s online service delivery enterprise Service Shop
It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies
The fund aims at investing in companies that extends human healthspan
Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time
The offline store launch will complement the E-commerce website in building a rich consumer shopping experience
This collaborative nursing conference generated a positive dialogue on how the healthcare space of nursing has evolved in the past year
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
Owkin builds best-in-class predictive biomedical AI models and robust data sets
Subscribe To Our Newsletter & Stay Updated
